Chr. Hansen develops natural ingredient solutions for the food, pharmaceutical, nutritional and agricultural industries
Quote | CHR Hansen Holding A/S ADR (OTCMKTS:CHYHY)
Last: | $19.585 |
---|---|
Change Percent: | 0.79% |
Open: | $19.43 |
Close: | $19.585 |
High: | $19.86 |
Low: | $19.42 |
Volume: | 7,343 |
Last Trade Date Time: | 02/26/2024 03:00:00 am |
News | CHR Hansen Holding A/S ADR (OTCMKTS:CHYHY)
2024-03-06 01:43:24 ET Summary Novozymes reported its last annual results for fiscal 2023 with revenue growing, but bottom line declining. Novonesis is the new company generated by the merger between Novozymes and Christian Hansen. The stock is trading above intrinsic value on...
2023-12-26 15:52:05 ET Summary Chr. Hansen Holding A/S is a Danish company with above-average growth potential in the enzymes business. The company recorded strong financial performance with 16% organic revenue growth and double-digit growth in core segments. The pending merge...
Message Board Posts | CHR Hansen Holding A/S ADR (OTCMKTS:CHYHY)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
CHR Hansen Holding A/S ADR Company Name:
CHYHY Stock Symbol:
OTCMKTS Market:
CHICAGO , July 28, 2020 /PRNewswire/ -- Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingred...